Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates—only 10% after five years.

The DAMO PANDA can accurately detect pancreatic cancer lesions, and FDA breakthrough therapy designation aims to accelerate ...

Pancreatic cancer has a notoriously low survival rate, with just 25% of patients living for a year or more after their ...

The FDA has approved Cabometyx for some patients 12 years old and older with previously treated neuroendocrine tumors.

Golden Bachelorette star Joan Vassos joined Good Morning Washington to advocate for more research and funding for the disease. (7News) ...

KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic ...